Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Changes

26 Jul 2017 10:02

RNS Number : 1398M
Johnson Matthey PLC
26 July 2017
Β 

Johnson Matthey Plc Directorate Changes

Β 

The board of Johnson Matthey Plc is pleased to announce the appointment of John O'Higgins, as a non-executive director of the company. He will join the board with effect from 16th November 2017.

Β 

John is currently Chief Executive of Spectris plc, a leading supplier of productivity-enhancing instrumentation and controls. He joined the board of Spectris plc as Chief Executive in January 2006. Prior to this John worked for Honeywell in a number of management roles, including as president of automation and control solutions, Asia Pacific. He began his career as a design engineer at Daimler-Benz in Stuttgart.

Β 

John will be replacing Colin Matthews CBE FREng, a non-executive director and Chairman of the Remuneration Committee. Colin is standing down from his role with effect from 15th November 2017 after five years on the board, having been appointed a non-executive director in October 2012 and Chairman of the Remuneration Committee in July 2016.

Β 

Chris Mottershead, a non-executive director, will be appointed as Chairman of the Remuneration Committee from 16th November 2017.

Β 

Tim Stevenson OBE, Chairman, commented:

Β 

"On behalf of all of us on the board I would like to thank Colin for his significant contributions during his time as a non-executive director.

Β 

I am very pleased to welcome John to the board and we look forward to working with him and benefiting from his extensive business and industrial experience".

Β 

Β 

Disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority (including directorships held in other publicly quoted companies at any time in the previous five years)

Β 

John was appointed as a director of Spectris plc in January 2006, a company listed on the London Stock Exchange.

Β 

From September 2010 to April 2015, John was a non-executive director of Exide Technologies, Inc, a company listed on the Nasdaq stock exchange.

Β 

Other than as stated in this announcement, there are no other disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority.

Β 

Enquiries:

Sally Jones

Director of Corporate Communications

020 7269 8407

Andrew Grant/David Allchurch

Tulchan Communications

020 7353 4200

www.matthey.com

26th July 2017

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAPGUGUMUPMUBQ
Date   Source Headline
18th Jan 20242:30 pmRNSHolding(s) in Company
18th Jan 202411:54 amRNSDirector/PDMR Shareholding
10th Jan 20241:29 pmRNSHolding(s) in Company
9th Jan 20241:31 pmRNSHolding(s) in Company
5th Jan 20244:50 pmRNSHolding(s) in Company
4th Jan 20244:26 pmRNSHolding(s) in Company
2nd Jan 20243:27 pmRNSHolding(s) in Company
28th Dec 20231:35 pmRNSHolding(s) in Company
21st Dec 20231:25 pmRNSDirector/PDMR Shareholding
19th Dec 20232:29 pmRNSHolding(s) in Company
15th Dec 20239:00 amRNSHolding(s) in Company
13th Dec 20233:01 pmRNSHolding(s) in Company
11th Dec 20234:20 pmRNSHolding(s) in Company
7th Dec 20231:41 pmRNSHolding(s) in Company
6th Dec 20231:52 pmRNSHolding(s) in Company
6th Dec 202312:00 pmRNSDirector/PDMR Shareholding
5th Dec 20232:56 pmRNSHolding(s) in Company
1st Dec 20233:56 pmRNSHolding(s) in Company
1st Dec 20233:54 pmRNSHolding(s) in Company
28th Nov 20239:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSBoard Committee changes
22nd Nov 20237:00 amRNSJohnson Matthey half year results
16th Nov 20234:23 pmRNSDirector/PDMR Shareholding
14th Nov 20233:16 pmRNSHolding(s) in Company
13th Nov 20234:33 pmRNSHolding(s) in Company
10th Nov 20238:00 amRNSHolding(s) in Company
25th Oct 20232:31 pmRNSHolding(s) in Company
24th Oct 20233:35 pmRNSHolding(s) in Company
23rd Oct 20234:30 pmRNSHolding(s) in Company
19th Oct 202312:26 pmRNSDirector/PDMR Shareholding
18th Oct 20239:00 amRNSHolding(s) in Company
16th Oct 20234:10 pmRNSHolding(s) in Company
10th Oct 20235:58 pmRNSHolding(s) in Company
10th Oct 20237:00 amRNSHolding(s) in Company
5th Oct 20232:30 pmRNSHolding(s) in Company
4th Oct 20232:21 pmRNSHolding(s) in Company
3rd Oct 20233:45 pmRNSHolding(s) in Company
3rd Oct 20238:00 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSCompletion of Diagnostic Services sale
29th Sep 20238:00 amRNSHolding(s) in Company
22nd Sep 20234:09 pmRNSHolding(s) in Company
22nd Sep 20231:59 pmRNSDirector/PDMR Shareholding
21st Sep 20234:22 pmRNSHolding(s) in Company
20th Sep 20233:31 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSHolding(s) in Company
15th Sep 20235:43 pmRNSHolding(s) in Company
13th Sep 20231:50 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSHolding(s) in Company
8th Sep 20238:00 amRNSHolding(s) in Company
5th Sep 20238:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.